Expression of the epidermal growth factor (EGF) was analyzed in six human hepatocellular carcinomaderived and one human hepatoblastoma-derived cell line, each of which retained the differentiated phenotype and functions of the parenchymal hepatocyte. The level of receptor expression of each hepatoma cell line was imilar to that of the normal human fibroblast, approximately 10 molecules per cell. However, NPLC/PRF/5, a subline of the PLC/PRF/5 cell line obtained following reestablishment of a xenograft tumor in vitro, was found to express 4 x 106 high-affinity EGF receptor molecules per cell. Proliferation of the NPLC/PRF/5 cell line was inhibited in the presence of nanomolar quantities of ligand. Receptor overexpression was found to result from EGF receptor gene amplification without apparent rearrangement of the EGF receptor coding sequences. Although cell-specific variability in posttranslational processing of EGF receptor N-linked oligosaccharides in the hepatoma cell lines was found, no difference between the receptors in PLC/PRF/5 and NPLC/PRF/5 was observed and no aberrant receptor-related species were detected. EGF receptor gene amplification in the NPLC/PRF/5 cell line is probably a reflection of genome instability and selection of variants with augmented growth potential in limiting concentrations of EGF in vivo. When viewed in this light, EGF receptor overexpression could represent a manifestation of tumor progression in the EGF-responsive hepatocyte.The adult parenchymal hepatocyte is a long-lived differentiated cell which can be stimulated to proliferate in a compensatory growth model. Although the molecular interactions which lead to liver cell proliferation are unknown, insulin, glucagon, and epidermal growth factor (EGF) are known to be necessary to the regenerative process (41). To determine whether abnormalities in the receptor for one growth factor implicated in the regulation of proliferation of the normal hepatocyte could be a factor in hepatocellular carcinogenesis, we examined the display of the EGF receptor in a series of hepatoma-derived cell lines. Increased expression of the EGF receptor has been observed in primary tumors and cell lines derived from human glioblastomas (31), pancreatic tumors (27), squamous cell carcinomas (22), and breast tumors (44). Hepatocellular carcinoma is a common tumor in areas of the world where hepatitis B virus (HBV) is endemic, but despite the frequent and stable integration of the HBV genome in these tumor cells, no viral transforming gene product and no common site of HBV integration within the host cell genomes have been identified (6, 12, 20a, 43, 49, 52). In the present analysis, we found that EGF receptor expression in the hepatoma-derived cell lines did not differ from that in normal cells, with the exception of one laboratory-derived subline of the PLC/PRF/5 hepatoma-derived cell line which expresses 20-fold more receptors per cell than the parental cell line, the result of EGF receptor gene amplification. Although receptor affinity for EGF was sim...